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The aim of this prospective follow-up study of children born after intracytoplasmic sperm injection (ICSI) was to compile data on karyotypes, congenital malformations, growth parameters and developmental milestones in order to evaluate the safety of this new technique. The study design included karyotyping of the parents and their agreement to genetic counselling and prenatal diagnosis and it was based on a physical examination of the child at the Centre for Medical Genetics at the ages of 2 months, 1 year and at 2 years, where major and minor malformations and psychomotor evolution are recorded. Here we describe the first 57 children born from 40 ICSI pregnancies with epididymal spermatozoa (group 1), the first 50 children born from 34 ICSI pregnancies with testicular spermatozoa (group 2) and the first 58 children born from 48 pregnancies after replacement of cryopreserved ICSI embryos (group 3). Parental karyotypes were obtained from only 72/246 (29%) parents and were all normal. Prenatal karyotypes were determined for a total of 70 samples (40%): 21 in group 1, 15 in group 2 and 34 in group 3. In this last group 2 abnormal 47,XXY karyotypes (5.8%) and no structural aberrations were found. This increase in denovo sex-chromosomal aberrations has already been described with regard to the first 877 children born after ICSI carried out at our Centre and is probably linked directly to the characteristics of the infertile men treated rather than to the ICSI procedure itself. Major malformations, defined as those causing functional impairment or requiring surgical correction, were observed in four children: two born after ICSI with epididymal spermatozoa, one after ICSI with testicular spermatozoa and one after ICSI and cryopreservation. No particular malformation was disproportionally frequent.
In the follow-up examinations at 2 months (107/ 161 or 66.5%) and at 1 year (37/161 or 22.9%), no additional anomalies were observed. Lost for follow-up rate at 2 months was 33.5%. These observations on a limited number of children do not suggest a higher incidence of diseases linked to imprinting, nor do they suggest a higher incidence of congenital malformations. These observations are still limited in number and should be further completed by others and by collaborative efforts. In the meanwhile patients should be told about the available data before any treatment: there appears to be some risk of transmitted chromosomal aberrations, of de-novo, mainly sex-chromosomal aberrations and of transmitting fertility problems to the offspring. Patients should also be reassured that until now there seems to be no higher incidence of congenital malformations in children born after ICSI with epididymal or testicular spermatozoa or after replacement of ICSI embryos.
Introduction When assisted fertilization and intracytoplasmic sperm injection (ICSI) were introduced, there was major concern about the safety of this new technique. ICSI is indeed a more invasive procedure, since one spermatozoon is injected through the oocyte membrane and since fertilization can be obtained using spermatozoa which could never have been used previously in fertility treatment. More questions arose and concern was expressed when ICSI with non-ejaculated spermatozoa, either epididymal or testicular, was introduced. Emphasis was placed on the fact that the risk of chromosomal aberration might be even higher in men with non-obstructive azoospermia. On the other hand, imprinting may be less complete at the time of fertilization if testicular spermatozoa are used. If this were so it would be unlikely to impair fertilization and early development, but anomalies might become manifest only later in postnatal life.
Experimentation in mice suggests that even under normal conditions parental genomes continue to be modified after fertilization, presumably prior to syngamy (Latham et al., 1995) . The regulatory factor must be present in one or both gametes at the time of fertilization and may be deficient in immature or in-vitro matured gametes. Bypassing gamete surface contact may decrease the ability of the egg cytoplasm to carry out such modifications. Unfortunately, there is no information on the mechanisms and exact timing of imprinting in the human embryo.
The safety of the ICSI procedure has been assessed carefully in previous publications (Van Steirteghem et al., 1993a,b,c; Bonduelle et al., 1994 Bonduelle et al., , 1995b Bonduelle et al., , 1996a Palermo et al, 1993 Palermo et al, , 1996 Devroey et al, 1995a,b) . This series of articles failed to demonstrate any increased risk of major congenital malformations as compared to the general population, but did find an increased risk of chromosomal aberrations, mostly sex-chromosomal aneuploidies. We also evaluated the results of the ICSI procedure by comparing the first group of 130 children born after ICSI with a control group of 130 matched children born after in-vitro fertilization (IVF) pregnancies in the same period of time and after the same ovarian stimulation and in-vitro culture conditions (Bonduelle et ah, 1995a) . In order to evaluate the safety of the ICSI procedure we compared the data on karyotypes, congenital malformations, growth parameters and developmental milestones in the two groups of children and could find no statistically significant differences. We thus concluded from this limited number of children that when ICSI was carried out and compared with standard IVF procedure, no additional risk was observed.
In a subsequent article, we evaluated the safety of the ICSI procedure by studying 877 children born after ICSI and a minority of children born after fertilization with epididymal and testicular spermatozoa as well as children born after ICSI in combination with cryopreservation (Bonduelle, 1996b) . In this article we decribe the separate groups of children born after the use of epididymal and testicular spermatozoa as well as children born after replacement of cryopreserved ICSI embryos; these data are compared with the previous findings in the ICSI group, so as to evaluate whether problems predicted from the literature are actually present.
Materials and methods
From the cohort of ICSI pregnancies obtained at the Centre for Reproductive Medecine of the Dutch-speaking Brussels Free University, three groups of children were studied (Table I) : group 1 consisted of 57 children, from the first 34 consecutive pregnancies born after replacement of embryos obtained after ICSI with epididymal spermatozoa; group 2 consisted of 50 children, from the first 40 consecutive pregnancies born after replacement of embryos obtained after ICSI with testicular spermatozoa; group 3 consisted of 58 children, from the first 48 consecutive pregnancies born after replacement of embryos obtained after replacemnt of cryopreserved ICSI embryos.
The follow-up of these cohorts of children was carried out at the Centre for Medical Genetics. In a previous article by our group a number of these children were described as part of the cohort of children born after ICSI: 29 children after ICSI using epididymal spermatozoa, 29 after ICSI using testicular spermatozoa and 22 after replacement of cryopreserved embryos obtained after ICSI (Bonduelle et al. 1996b) . Of the 58 children born after the replacement of cryopreserved ICSI embryos described here, three were born after the use of testicular spermatozoa and 14 after the use of epididymal spermatozoa, in the initial treatment cycle. These 17 children were counted twice into two groups: one taking into account the origin of the spermatozoa and one taking into account the cryopreservation procedure.
The design of the prospective follow-up study was as follows. Before starting ICSI, couples were asked to adhere to the follow-up conditions of our study. These conditions included genetic counselling and agreement to prenatal karyotype analysis as well as participation in a prospective clinical follow-up study of the children. They also included completion of the standardized questionnaire as described in the article by Wisanto et al. (1995) , returning it to the research nurse and when possible visiting the Centre for Medical Genetics with the child after birth.
All couples referred for assisted fertilization were evaluated for possible genetic problems, either before starting treatment in cases of maternal age >35 years, positive family history or a chromosomal aberration carried by a parent, or at 6-8 weeks of pregnancy. A history, including a pedigree, was obtained in order to identify genetic risks or possible causes of congenital malformations. This history included details of medication, alcohol abuse, environmental or occupational risk factors and socio-economic status. A karyotype was routinely performed for the couple. In view of possible risk factors due to the new techniques of assisted fertilization, the couple was counselled about the risks of chromosomal abnormalities and the desirability of having a prenatal test (Bonduelle et al., 1996b) . Pros and cons of the different types of prenatal diagnosis were discussed in detail at ~6-8 weeks of gestation; amniocentesis was suggested for singleton pregnancies, while chorionic villus sampling was proposed for multiple pregnancies (De Catte et al., 1996) . Chromosome preparations were obtained from cultured amniocytes according to a modified technique by Verma et al. (1989) . Chromosome preparations from non-cultured and cultured chorionic villus cells were obtained by means of the technique described by Gibas et al. (1987) and Yu et al. (1986) respectively. If indicated, prenatal tests for other genetic diseases were planned.
The follow-up study of the expected child was further explained: it was to consist of a visit to the clinical geneticist at 2 months and at 12 months of age, and then once a year.
For all pregnancies, written data on pregnancy outcome with regard to the babies were obtained from the gynaecologists in charge. Perinatal data, including gestational age, mode of delivery, birthweight, Apgar scores, presence or absence of malformations and neonatal problems were registered. If any problem was mentioned, detailed information was also requested from the paediatrician in charge.
For babies born in our university hospital, a detailed physical examination was performed at birth, which looked for major and minor malformations and included evaluation of neurological and psychomotor development. For babies born else-where, written reports were obtained from gynaecologists as well as from paediatricians, while a detailed morphological examination by a clinical geneticist from our centre was carried out after 2 months whenever possible. Additional investigations were carried out if the anamnestic data or the physical examination suggested them.
At the follow-up examination at 12 months and 2 years, the physical, neurological and psychomotor assessments were repeated by the same team of clinical geneticists. At ~2 years or more, a Bayley test was programmed in order to quantify the psychomotor evolution of the children. If parents did not spontaneously attend the follow-up consultations, they were reminded by phone to make an appointment. For parents living abroad, reminders were mailed.
A widely accepted definition of major malformations was used, i.e. malformations that generally cause functional impairment or require surgical correction. The remaining malformations were considered minor. A minor malformation was distinguished from normal variation by its occurrence in =£4% of the infants of the same racial group. Malformations or anomalies were considered synonymous with structural abnormality (Smith, 1975; Holmes, 1976) .
Results
From the pregnancy cohort (positive serum human chorionic gonadotrophin) of 73 pregnancies in group 1, 77 pregnancies in group 2, and 79 pregnancies in group 3 we obtained data for only 94% of the ongoing pregnancies, even after several attemps to obtain the information. In group 1 we had complete data (partly from the paediatricians and partly from the parents) for 57 children at birth and incomplete data for one child; in group 2 we had complete data for 50 children and incomplete data for nine children; in group 3 we had complete data for 58 children and incomplete data for two (the same two as in the previous groups). In group 1 (after use of freshly collected or frozen-thawed epididymal spermatozoa), of the 57 children studied, 26 were singletons, 22 were from twin pregnancies and nine were from triplet pregnancies; two twin children in separate pregnancies suffered an intrauterine death (defined as fetal death 3=20 weeks or ^=400 g) and 55 were liveborn.
In group 2 (after use of testicular spermatozoa), of the 50 children studied, 21 were singletons, 20 were from twin pregnancies and nine were from triplet pregnancies. In group 3 (after replacement of cryopreserved embryos obtained after ICSI), of the 58 children studied, 38 were singletons and 20 were from twin pregnancies; two singleton pregnancies were interrupted for an abnormal prenatal karyotype (twice a 47,XXY karyotype) and 56 children were liveborn. The sex ratio in the different subgroups is shown in Table II .
The mean maternal age as regards the children born was 32.2 years (range 22.9^4-2.5) in group 1, 32.1 years (range 24.0-41) in group 2 and 31.9 (range 24.9^2.5) in group 3 (Table III) . The mean paternal age as regards the children born was 39.2 years (range 30-60.4) in group 1, 37.2 years (range 29.4-46.3) in group 2 and 34.0 (range 26.8^2.5) in group 3.
We obtained data from physical examination at birth for all the children. We compiled this information from the medical records as well as from careful questioning of the parents during follow-up consultations. For the children living further away, or where the parents were no longer willing to come to the clinic, detailed histories (except for one major malformation where we were given only the name of the malformation) were obtained from the paediatrician if any problem was mentioned in answers to the questionnaire.
During the follow-up at 2 months, 33/55 children in group 1, 30/50 in group 2 and 44/56 children in group 3 were examined by one of the geneticists; for 11, 16 and nine children information was obtained from letters from parents or paediatricians. in nine couples had a 1/4 risk for a cystic fibrosis (CF) child because both parents were carrier of a CF mutation. CBAVD = congenital bilateral absence of the vas deferens.
At 2 months of age lost for follow-up rate was thus respectively 40, 40 and 21%. So far 14/55, 10/50 and 13/56 children have been examined a second time at 1 or 2 years of age. Most of the children are still <2 years of age.
Genetic counselling
We obtained only a limited number of the routine karyotype examinations of the parents: 11/39 women and 11/39 men in group 1, 6/36 women and 8/36 men in group 2 and 14/48 and 22/48 in group 3. Although referring to a limited number of parents, all these karyotypes were normal.
At the genetic counselling session, we saw the parents of 24 of the 57 children in group 1, the parents of 15/50 children in group 2 and the parents of 31/58 in group 3. Foreign parents often did not attend the genetic consultation as they had left the country before the appointment. The risks discussed during this session are given in Table III . Maternal age 5=35 years was a factor for seven mothers and paternal age above 50 was a factor for two fathers in group 1; maternal age risk was present for six and eight mothers in groups 2 and 3 respectively. Nine fathers in group 1 had congenital bilateral absence of the vas deferens (CBAVD). After screening all the partners of CBAVD patients we found one couple to have a 1/4 risk of cystic fibrosis (CF). For this couple a preimplantation diagnosis for CF was proposed and successfully carried out (Liu et al., 1994) .
In group 2, one CF patient with CBAVD was counselled about the residual risk of CF in the children. The same patient was also present in group 3. One other CBAVD patient from group 1 was also present in group 3.
Prenatal diagnosis
In all, 70 prenatal tests were performed, one of which was a control sample for a previous test (Table IV) ; 21 samples were collected in group 1, 15 in group 2 and 34 in group 3. Of these 70 tests, none were abnormal in groups 1 and 2 and two were abnormal in the group of cryopreserved embryos. These two were 47,XXY karyotypes and both sets of parents opted for an interruption of the pregnancy. No inherited or de-novo structural aberrations were found.
Chorionic villus sampling was performed for two fetuses in group 1, two in group 2 and eight in group 3; amniocentesis was performed for 19 fetuses in group 1, 13 in group 2 and 26 in group 3. No spontaneous interruptions after test procedures were noted.
Neonatal data
Neonatal measurements for 55, 50 and 56 liveborn children of >20 weeks of gestation in groups 1, 2 and 3 and birthweights for singletons, twins and triplets are listed in Table V. Prematurity (birth before 37 weeks of pregnancy) occurred in seven of the 40 pregnancies, including the births of 14 twins in group 1; in group 2, five pregnancies ended prematurely, involving the births of 10 twins; and in group 3, three pregnancies ended prematurely involving the births of six twins. Birthweight <2500 g was noted for 16 children (all were multiples) in group 1, for 19 children (10 multiples) in group 2 and eight (six multiples) in group 3. No neonatal deaths occurred.
Major malformations (Table VI)
For one child in group 1, ureteral dilatation was detected before birth during ultrasound examina- Minor malformations (Table VII ) These were found in 4/55 children in group 1, 3/ 50 in group 2 and 7/56 in group 3. These children did not have major anomalies. Surgery Surgery was needed for one child with an inguinal hernia in group 1 and for the children in groups 1 and 3 with major malformations.
At the age of 2 months, no new major or minor malformations were found. Minor malformations observed at birth did not cause any functional impairment.
Follow-up
Follow-up at the age of 2 months was still limited up to the date 1 May 1996: 33/55 children of group 1, 30/50 children of group 2 and 44/56 children of group 3. Twenty-two, 14 and 35 children came to the Centre while for the others we received information about development from the paediatricians or the parents. At 1 year we saw 14, 10 and 13 children respectively. In group 1, two children had a minor developmental problem; one child had an axial hypotonia at 2 months, but was normal at 2 years and one child had a language delay at 2 years. No neurological problems were encountered in the children during follow-up consultations.
Discussion
From the beginning of our ICSI treatment, nearly all patients have been seen at the Centre for Medical Genetics either before starting the treatment or at 6-8 weeks of pregnancy. Since in the group treated with epididymal and testicular spermatozoa many patients live outside Belgium, these tended to leave the country early and not to attend the genetic counselling session. We have seen only 43% of the couples in group 1, 30% in group 2 and 55% in group 3. Apart from the maternal age risk, the risk associated with CBAVD was most frequent; in group 1, 9/55 or 16% of the children had an increased risk of CF and of CBAVD. Screening for CF is therefore mandatory. One of the couples had a 1/4 risk of CF; for this couple we proposed a preimplantation diagnosis, which was accepted. From the frequency of CF carriers in the populations with European ancestry we expect a 1/4 risk for 4-5% of the couples (Collins et al., 1992) . We think that for couples with a fertility problem requiring an ICSI treatment in combination with a genetic high-risk situation, preimplantation diagnosis should be offered whenever feasible. In group 2 (and for the same patient who was present in group 3), a homozygous CF patient was treated successfully. This patient's risk of having a CF child was, when the wife had been screened for a standard mutation set of eight frequent mutations in our populaton, 1/150X1/2 = 1/300. This inevitable risk was explained to the couple, who accepted it.
During the genetic consultation we did not detect monogenic disease apart from the CF patient in groups 2 and 3, where the diagnosis was made during the investigations for his fertility problem. Even if we did not find many genetic diseases we are aware of the fact that a fertility problem may be one of the expressions of a more general disease. As expressivity can vary a lot, as for example in myotonic dystrophy, it is important to draw a complete pedigree and to screen family members for other than reproductive problems. We also think it necessary to continue to perform parental karyotypes, since for couples with a numerical abnormality of the chromosomes, a mosaicism or a structural aberration, the global chances of success of the treatment procedure can be reduced and the stronger indications for a prenatal test and the risks for the offspring should be discussed (Hens et al., 1988) . As we know from our own experience with ICSI patients (Bonduelle et al., 1996b; Van Assche et al., 1996) as well as from the literature data (Chandley et al., 1979; Yoshida et al., 1995) there is a higher risk of chromosomal abnormality in male-fertility patients and we should persuade gynaecologists to perform a karyotype before starting any treatment cycle. Yoshida found in a review of 1007 males with infertility, 14.6% chromosomal aberrations in the azoospermic males and as high as 20.3% chromosomal aberrations in the non-obstructive azoospermia cases. If we did not see any anomaly in the chromosomes of these groups it is probably because only eight men were tested and we probably missed the opportunity to discuss a prenatal diagnosis in some higher-risk situations.
Since we also know that meiotic errors can occur more frequently in azoospermic men (Pang et al., 1994 (Pang et al., , 1995 and also in infertile men in general (Moosani et al., 1995) , it would also be of help for future counselling if chromosome analysis of germ cells were to become possible on a routine basis in order to discriminate some highrisk situations.
Although most patients were informed through the informed consent procedure and from the oral information from gynaecologists and nurses about the risks of chromosomal aberrations in ICSI pregnancies in general, only 21/57 (37%) fetuses in group 1, 15/50 (30%) in group 2 and 34/58 (58%) in group 3 were tested, more singletons (58/ 85 or 68%) than multiples (12/80 or 15%). More parents of a multiple pregnancy were afraid of the test procedure as we counselled them to have chorionic villus sampling rather than amniocentesis and attributed a higher risk (of 1%) of miscarriage to the latter. Most of the couples withdrew from testing once pregnant because the risk of miscarriage after a fertility treatment was considered too high or because of ethical or religious considerations, which were more frequent in groups 1 and 2 since some of these patients were practising Jews and different from our previously described ICSI population. We know from our experience with ICSI that in this situation the risk of a de-novo chromosomal aberration is no higher than the risk to 37 year old women in the general population [based on Ferguson-Smith's (1983) calculation at 1.2%]. In these particular subgroups, however, where testicular or epididymal spermatozoa were used, there could be a higher risk of de-novo (sex) chromosomal and inherited chromosomal aberrations. As we did not put moral pressure on the patients if they did not wish to accept the added risk from testing, we obtained karyotypes for only 70 of the 165 (42%) fetuses.
Abnormal fetal karyotypes were not found in groups 1 and 2. This is not what we expected from our experience with ICSI, where 1.2% aneuploidies were found (Bonduelle et al, 1996b) . Moreover, for many patients we did not have the karyotype after birth. As we expect mainly sex-chromosomal aberrations, these could have been missed in a simple clinical evaluation. We must therefore conclude that we do not have enough data in groups 1 and 2 to draw conclusions about the risk of chromosomal anomalies in this limited sample.
In the group with cryopreserved embryos obtained after ICSI with ejaculated spermatozoa, we found that two of 34 tested fetuses (5.8 %) were abnormal. Both abnormalities consisted of the same sex-chromosomal aberration, a 47,XXY karyotype or Klinefelter syndrome. Apart from the fertility problem, the clinical picture can vary a lot, and patients were informed as objectively as possible. Both parents opted for a second-trimester abortion. Maternal age was 26 and 31 years and paternal age was 28 and 31 years. The origin of the extra X chromosome was checked by DNA polymorphism (DXS52) for one pregnancy and this was paternally derived. We think that this higher incidence of abnormal fetal karyotypes in pregnancies after replacement of cryopreserved ICSI embryos is probably only a statistical variation of a higher risk of sexchromosomal aberrations found in the ICSI pregnancies (Bonduelle et al, 1996b) as there is no theoretical ground to suppose that the cryopreservation technique could induce chromosomal aberrations of this type, which are present already before the first mitotic division. The mean maternal age of the mothers conceived in group 3 was 31.9 years, and the mean paternal age was 34 years, which does not explain the higher rate of chromosomal aberrations. For a mean maternal age of 32 years we would expect a figure of ~0.3% chromosomal aberrations at the time of prenatal diagnosis (Hook et al., 1977; Ferguson-Smith, 1983) .
In our previous group of ICSI patients, we described 1.2% family-based structural aberrations. They were certainly not induced by the microinjection technique, since they were all detected in the infertile males before their treatment. Statistically, family-based structural aberrations can lead to normal karyotypes, to exactly the same structural aberration as in the parent, or to 0-50% of nonbalanced karyotypes. In this limited group of parents, no father was found to carry a structural aberration and no fetuses with an unbalanced karyotype were found.
The figure of 2.4% or four major malformations out of 161 liveborn children is similar to most of the general population national registries (Office of Population Censuses and Surveys, 1982-88, 1987-88 ; National Perinatal Statistics Unit and Fertility Society of Australia, 1992) and the assisted reproduction surveys (Saunders et al., 1987; Cohen, et al, 1988; Beral et al, 1990; Rizk and Dole, 1991; Friedler et al, 1992; Medical Research International, 1992; Rufat et al, 1994 , Bachelot et al, 1995 , Lancaster et al, 1995 . We here considered the livebirth malformation rate as this is the most frequently used, rather than a more precise calculation of the ratio, taking fetal deaths and interruptions of affected fetuses into account, which is used in only very few malformation surveys. However, the more intensive follow-up of ICSI pregnancies and the frequent fetal karyotypes could theoretically lead to an increase in the number of terminations artificially decreasing the observed rate of malformations at birth. In this survey two pregnancy interruptions for Klinefelter syndrome were performed; if these children were born they would probably not have been counted in the figure of major malformations. No malformations were observed by ultrasound and therefore there was no need to consider other pregnancy interruptions. National registries most often register the anomalies at birth or during the first week of life, while in this study the follow-up is carried through to 2 years. Moreover, risk figures in the national statistics will probably also be somewhat lower as it is unlikely that malformations are generally searched for as carefully as in this survey. We found two malformations in the first group: a unilateral hip and leg malformation for which we do not know whether a genetic or environmental mechanism was to blame, or the treatment procedure itself; the other malformation was a urogenital malformation, to which we know that there is often a genetic basis besides an environmental factor.
In the group receiving ICSI with testicular spermatozoa, a child with a cleft lip and palate was found. In this case, where the mother was not exposed to drugs or medication during pregnancy and where no associated malformations were found, there was probably a multifactorial problem. The fact that after 2 months the child died of a degenerative muscle disease is probably a second problem with a monogenetic basis. Unfortunately we do not have the exact diagnosis for this child.
In the third group a child with a cleft lip and palate in combination with a unilateral hand and foot malformation and an intrauterine growth retardation was found. As we do not have the exact diagnosis we do not know the mechanism behind this malformation. Closure of lip and palatum occurs before the 12th week of pregnancy. A karyotype analysis performed on cord blood was normal 46,XY.
As we saw only one-third of the children at 2 months of age and as we know that the lost for follow-up data can vary considerably from the collected data, firm conclusions on the rate of major malformations cannot be drawn. As we compare our data on ICSI children born afer replacement of cryopreserved embryos with the data of Olivennes et al. (1996) , on children born after IVF and cryopreservation, we found 1/56 major malformations where Olivennes et al. found 1/89 major malformations. In this group the lost for follow-up rate was considerably better and only 4.3%.
During follow-up consultations we have seen 37 children until now and we have not encountered any major developmental problem, apart from in those children with major malformations.
A number of hypotheses exist to support the idea of an additional risk due to the ICSI procedure and in particular due to the use of epididymal or testicular spermatozoa. Selective mechanisms against physiologically or genetically abnormal spermatozoa might be bypassed; abnormal oocytes might be fertilized; the altered environment or mechanical or chemical damage to the oocyte might lead to perturbations of meiosis and mitosis; various chemical or environmental exposures might also lead to point mutations resulting in genetic disease visible at birth or later in life. With the use of immature testicular spermatozoa, diseases linked to imprinting were expected to occur more often.
With normal morphology and normal developmental processes observed so far, there seem to be none of the expected problems. Caution is still needed, since many of the problems due to abnormal imprinting would be detectable only during later development.
Conclusion
In this follow-up study of children born after ICSI, a slight increase in de-novo chromosomal aberrations of 5.8% (2/34) on prenatal diagnosis in the group of children born after replacement of cryopreserved ICSI embryos is probably directly linked to the characteristics of the infertile men treated rather than to the ICSI technique itself.
In the group of children born after ICSI with epididymal or testicular spermatozoa we failed to find a higher risk in a limited sample of 36 prenatal tests.
Major malformations were found in an expected range of 2.4% (4/161), comparable to the figures from other studies after assisted reproductive techniques or in population registries, but the one-third of children lost for follow-up at the age of 2 months must be mentioned.
These observations should be further by others and by collaborative efforts. Meanwhile, patients should be counselled on the basis of the available data before any treatment: the higher risk of transmitted chromosomal aberrations, the risk of de-novo, mainly sex-chromosomal, aberrations and the risk of transmitting fertility problems to the offspring. They should also be reassured that there so far seems to be no higher incidence of congenital malformation or developmental problems in children born after ICSI with epididymal or testicular spermatozoa or after replacement of frozen-thawed ICSI embryos.
